It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
Medical Tourism will boost India’s economy
The company is adding new capabilities of Combi-line for Microsphere, additional Bag line and lyos for the Penem block in Pashamylaram facility in Hyderabad and will be earmarking capital for further building on its Biosimilar CDMO facility
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
There is a great opportunity for utilizing traditional medical practices like Ayurveda in Value Based Healthcare
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers
Subscribe To Our Newsletter & Stay Updated
